TTT-3002

Known as: FLT3 Tyrosine Kinase Inhibitor TTT-3002 
An orally bioavailable indolocarbazole derivative and inhibitor of constitutively active mutant forms of FMS-like tyrosine kinase 3 (FLT3) with… (More)

Topic mentions per year

Topic mentions per year

2013-2013
0120132013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
More than 35% of acute myeloid leukemia (AML) patients harbor a constitutively activating mutation in FMS-like tyrosine kinase-3… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2014
2014
There have been a number of clinical trials testing the efficacy of FMS-like tyrosine kinase-3 (FLT3) tyrosine kinase inhibitors… (More)
Is this relevant?
2014
2014
http://bloodjournal.hematologylibrary.org/content/123/10/1525.full.html Updated information and services can be found at: (1146… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2014
Review
2014
There have been a number of clinical trials testing the efficacy of FLT3 tyrosine kinase inhibitors (TKIs) in acute myeloid… (More)
Is this relevant?
2013
2013
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most frequent known cause of late-onset Parkinson's disease (PD). To… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?